The Archive
-
Pioneering journal eLife faces major test after loss of impact factor -
Publishers are selling papers to train AIs — and making millions of dollars
-
New schizophrenia drug could treat Alzheimer’s disease
-
AI-generated images threaten science — here’s how researchers hope to spot them
-
‘Smart’ insulin prevents diabetic highs — and deadly lows
-
HIV: how close are we to a vaccine — or a cure?
-
Debate rages over Alzheimer’s drug lecanemab as UK limits approval
-
AI is complicating plagiarism. How should scientists respond?
-
Your reagent is past its use-by date. Should you bin it?
-
Cyberattacks are hitting research institutions — with devastating effects
